BCL2L1 and cancer: The inhibition of antiapoptotic Bcl-2 and Bcl-XL, and induction of proapoptotic Bax, Bak, PUMA, Noxa, Bim, and Bid proteins by resveratrol suggest that the relative expression of these proteins can determine the sensitivity of cancer cells to TRAIL.